Hydroxyapatite matrix in bone (HA matrix (used for hydroxyapatite, though not a standard abbreviation for the complete matrix))

Hydroxyapatite matrix in bone refers to the inorganic mineral component of bone, composed primarily of hydroxyapatite (Ca₁₀(PO₄)₆(OH)₂) crystals embedded within a collagen matrix. This rigid matrix provides bones with their mechanical strength and rigidity and comprises about 60–70% of the bone's dry weight. Hydroxyapatite is essential for bone mineralization, serving both as a structural material and as a reservoir for calcium and phosphate. In bone regeneration, hydroxyapatite is crucial for osteoconduction (guiding new bone growth) and osteoinduction (inducing the differentiation of bone-forming cells). While hydroxyapatite itself is not a conventional drug target such as a receptor or enzyme, it is central to the mechanism of action of several osteoporosis therapies (notably bisphosphonates) and is widely utilized as a scaffold in bone graft and repair procedures[1][2][3][4][5][6][7]. It is not a cellular or protein target and thus does not strictly meet the definition of a "therapeutic target" in a pharmacological sense. The "hydroxyapatite matrix" label is strictly material and structural, not a single molecular or receptor entity.

Other names

HydroxyapatiteBone hydroxyapatiteBone mineral

Bisphosphonates: adsorb to hydroxyapatite crystals and are taken up by osteoclasts during resorption, inhibiting their function and inducing apoptosis[5]. Fluoride: replaces hydroxyl groups in hydroxyapatite, forming more acid-resistant fluorapatite which influences bone and dental tissue stability[5].